Pluristem Therapeutics Inc (PSTI)

[Scott999]

From Barda's 2017 budget.

PROJECT BIOSHIELD: $350 MILLION: BARDA would make six procurements through Project BioShield: new antimicrobial drugs to address biothreat pathogens; a new acute radiation syndrome MCM; new biodiagnostic for anthrax; a new high-throughput biodosimetry diagnostic device; and, a new Ebola therapeutic and vaccine candidates.

Seems like it is between us and CBLI. Or does anyone know of any other advanced ARS possibility. Biothrax got a $100 million purchase over 2 years from Barda in March. That's the only one I could find.

Interesting few months ahead.